HLI

Over the past six months, several events have impacted Houlihan Lokey's stock price. HLI reported its Q2 fiscal year 2026 earnings, after which its shares declined by 10.1%. Following the announcement of its Q3 fiscal year 2026 results, HLI shares experienced a 6.5% decline. Director Robert A. Schriesheim sold 5,000 shares of HLI stock on February 6, 2026. General Counsel Christopher M. Crain sold 500 shares on April 1, 2026. Several major firms lowered their price targets for HLI in early April 2026, but most maintained "buy" or "outperform" ratings. Houlihan Lokey reported record annual revenue of $2.62 billion for fiscal year 2026, a 10% increase year-over-year, and adjusted EPS of $7.56, up 20%; the stock rose 1.15% in aftermarket trading, and the board announced a 17% increase in the quarterly dividend to $0.70 per share.